A semi-automated neutral red based chemosensitivity assay for drug screening |
| |
| Authors: | Paul F. Cavanaugh Jr. Patricia S. Moskwa William H. Donish Paula J. Pera Debra Richardson Angelo P. Andrese |
| |
| Affiliation: | (1) Chemotherapeutics Research Laboratory, Eastman Kodak Company, 14650 Rochester, New York, USA;(2) Sterling Research Group, Sterling Drug Inc., 19355 Malvern, PA, USA;(3) Life Sciences Research Laboratories, Eastman Kodak Company, 14650 Rochester, New York, USA |
| |
| Abstract: | Summary A semi-automated colorometric chemosensitivity assay was developed. The assay utilizes the vital stain neutral red for the rapid screening of potential anticancer agents using solid tumor cell lines. The cell lines used in this assay and presented in this report are CX-1 colon adenocarcinoma and A549 lung carcinoma. The assay, performed in 96 well tissue culture plates, allows for short drug exposure times (3 hrs.) followed by quantitation of cell number (neutral red absorbance) following four cell doubling times.Cell number directly correlated with absorbance of eluted neutral red at 540 nm. However, optimal amounts of dye and staining times varied between cell lines.IC50 concentrations (for inhibition of cell growth) determined using this assay were in good agreement with results from clonogenic assays using similar drug treatment conditions.The assay technique was determined to be capable of detecting antineoplastic compounds operating by a wide variety of mechanisms. |
| |
| Keywords: | anticancer drug screening neutral red cell culture chemosensitivity |
| 本文献已被 SpringerLink 等数据库收录！ |
|
